Name
Designations
Role
GMC number
My current role
I have wide experience in the management of head and neck, thyroid and skin cancers. I have active clinical research interests and I am the local Principal Investigator for national clinical trials.
My research aim is to individualise RT prescriptions, increasing dose in tolerant patients and modifying dose in sensitive patients. My work focuses on determining factors that influence outcomes from radiotherapy treatment and the wide variation in RT toxicity experienced. This includes patient-related factors, e.g. smoking; treatment-related factors, and genetic factors (radiogenomics). I am the Chief Investigator for RAPPER, a large UK radiogenomics study and a member of the international Radiogenomics Consortium.
I am Chair of the Fellowship of the Royal College of Radiologists Part 1 Exam Board.
Previous history
I qualified in medicine from Oxford University and subsequently trained in Oxford, Bath, Nottingham and Cambridge. I was awarded a PhD from the University of Cambridge in February 2012.
Memberships and accreditations
Fellow of the Royal College of Radiologists.
Personal interests
I enjoy running, cycling, music and textiles.
Publications
-
Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers
-
Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity
-
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity
-
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study
-
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype